BioXcel Therapeutics
BTAI
#10140
Rank
โ‚น0.74 B
Marketcap
โ‚น135.55
Share price
-12.91%
Change (1 day)
-96.15%
Change (1 year)

BioXcel Therapeutics (BTAI) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น3.45 Billion

According to BioXcel Therapeutics's latest financial reports the company has โ‚น3.45 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น5.42 B-66.13%
2022-12-31โ‚น16.03 B-7.55%
2021-12-31โ‚น17.34 B11.25%
2020-12-31โ‚น15.58 B574.05%
2019-12-31โ‚น2.31 B-22.31%
2018-12-31โ‚น2.97 B5155.08%
2017-12-31โ‚น56.63 M
2016-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น21.89 B 533.77%๐Ÿ‡บ๐Ÿ‡ธ USA